Results 1 to 10 of about 9,696,955 (392)

Modern and Convensional Wound Dressing to Interleukin 1 and Interleukin 6 in Diabetic wound [PDF]

Jurnal Ners, 2015
Introduction:Holistic wound care is one of the ways to prevent gangrene and amputation, modern wound dressing is more effective than convensional with increasing transforming growth factor and cytokine, especially interleukin. This study aims to identify
Werna Nontji, Suni Hariati, Rosyidah Arafat   +2 more
doaj   +3 more sources

Interleukin 6: friend or foe in diabetic nephropathy? [PDF]

Archives of Medical Science
Introduction This study aimed to investigate the relationship between serum cytokine levels, particularly interleukin 6 (IL-6), and diabetic nephropathy (DN) in patients with type 1 (T1D) and type 2 diabetes (T2D). Material and methods A cross-sectional
Renad M. Alhamawi, Walaa Mohammedsaeed, Maha Aljumaa   +2 more
doaj   +2 more sources

Giant Cell Arteritis Refractory to Interleukin‐6 and Interleukin‐17 Inhibition Treated With Upadacitinib [PDF]

ACR Open Rheumatology
Giant cell arteritis (GCA) is a granulomatous vasculitis that can involve both cranial and extracranial vessels. Although interleukin‐6 (IL‐6) receptor blockade is an established therapy, treatment options for medically refractory disease remain limited.
Luke S. Vest, Anam Ahmad, Sanhitha Valasareddy, Nancy Phillips, Adam Kilian   +4 more
doaj   +2 more sources

P-769. Utility of Urinary Interleukin-6 to aid in the Diagnosis and to assess Prognosis in Urinary Tract Infections [PDF]

Open Forum Infect Dis
Anupam Dey, Soumya Kanti Mandal, Debapriya Bandyopadhyay, Debananda Sahoo, Ashoka Mahapatra   +4 more
europepmc   +2 more sources

Interleukin 6 in aging and age­-related diseases

Klinicist, 2021
Modern concepts about the importance of subclinical inflammation in various age-associated pathology are described in the review. The term “inflammaging” (inflammation due to aging) refers to the special role of inflammation in the aging processes.
S. V. Topolyanskaya
doaj   +1 more source

Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses [PDF]

Shock, 2003
Genetic variations contribute to differences in the inflammatory response and are markers for disease risk and outcomes. We studied three single-nucleotide polymorphisms (-597 G-->A, -572 G-->C, and -174 G-->C) in the IL-6 promoter to determine associations with ex vivo LPS-stimulated IL-6 production by leukocytes.
Fernando A, Rivera-Chavez, Dixie L, Peters-Hybki, Robert C, Barber, Grant E, O'Keefe   +3 more
openaire   +2 more sources

Interleukin 6 in aging and age-related diseases

Klinicist, 2020
Modern concepts about the importance of subclinical inflammation in various age-associated pathology are described in the review. The term “inflammaging” (inflammation due to aging) refers to the special role of inflammation in the aging processes.
S. V. Topolyanskaya
doaj   +1 more source

Interleukin-6, age, and corpus callosum integrity. [PDF]

, 2014
The contribution of inflammation to deleterious aging outcomes is increasingly recognized; however, little is known about the complex relationship between interleukin-6 (IL-6) and brain structure, or how this association might change with increasing age.
Bettcher, Brianne M, Busovaca, Edgar, Dutt, Shubir, Green, Ralph, Kramer, Joel H, Lobach, Iryna V, Miller, Bruce L, Miller, Joshua W, Neuhaus, John, Patel, Nihar, Rosen, Howard J, Walsh, Christine M, Watson, Christa L, Yaffe, Kristine   +13 more
core   +6 more sources

Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting

Journal of Cachexia, Sarcopenia and Muscle, 2022
Background Sepsis and inflammation can cause intensive care unit‐acquired weakness (ICUAW). Increased interleukin‐6 (IL‐6) plasma levels are a risk factor for ICUAW. IL‐6 signalling involves the glycoprotein 130 (gp130) receptor and the JAK/STAT‐pathway,
Lukas Zanders, Melanie Kny, Alexander Hahn, Sibylle Schmidt, Sebastian Wundersitz, Mihail Todiras, Ines Lahmann, Arnab Bandyopadhyay, Tobias Wollersheim, Lars Kaderali, Friedrich C. Luft, Carmen Birchmeier, Steffen Weber‐Carstens, Jens Fielitz   +13 more
doaj   +1 more source

P-65. Clinical and microbiological characteristics of bacteremia in anti-interleukin-6 inhibitor recipients [PDF]

Open Forum Infect Dis
Koh Shinohara, Yusuke Tsuda, Yasuhiro Tsuchido, Masaki Yamamoto, Yasufumi Matsumara, Miki Nagao   +5 more
europepmc   +2 more sources